BioSpace News Archive

BioCapital

Statement From FDA Commissioner Scott Gottlieb, M.D., on Steps to Promote Development of Generic Versions of Opioids Formulated to Deter Abuse

As we continue to confront the staggering human and economic toll created by opioid abuse and addiction, we’re focused on taking actions that reduce the scope of new addiction by decreasing unnecessary exposure to opioids.

November 21, 2017

·

6 min read

Deals

Alpha Source Closes Bc Technical Business Deal Creating One of The Largest Independent Imaging and Medical Equipment Service Companies in the U.S.

The acquisition doubles the size of Alpha Source and creates one of the largest independent full service, imaging services and equipment repair solutions companies in the U.S.

November 21, 2017

·

4 min read

Symcel Secures €3.6 Million Horizon 2020 Phase II Grant for Clinical Validation of Customized Antimicrobial Susceptibility Testing Multi-Resistant Bacterial Sepsis Infections to be Validated Utilising Symcel’s Sensitive Screening Technology

The project runs over 28 months with a consortium of internationally recognized academic and clinical key opinion leaders from Karolinska Institutet, Hospital Universitario Ramón y Cajal, Careggi University Hospital, Rigshospitalet, IHE and Symcel.

November 21, 2017

·

4 min read

Heidelberg Pharma AG Raises Approximately EUR 34.4 Million From Capital Measure

Heidelberg Pharma AG will receive gross issue proceeds of EUR 34,427,274 million from the corporate action, which will be used to finance the Company’s ATAC development programs.

November 21, 2017

·

3 min read

Deals

Avantor Completes Acquisition of VWR

VWR will operate as a wholly-owned subsidiary of Avantor.

November 21, 2017

·

5 min read

Biovica Release: New Study Results Support Use of DiviTum TK1 Biomarker Assay for Evaluation of Pancreatic Cancer

he proof of concept study, including 404 patients, provides evidence for using DiviTum as a dynamic biomarker before and during therapy to give important answers regarding prognosis and how effective therapy is.

November 21, 2017

·

3 min read

Drug Development

Anatara Lifesciences Presents at Australasian Pig Science Association Conference

A single dose of Detach at weaning was as effective as in-feed ZnO in reducing diarrhoea and antibiotic treatments in piglets post-weaning compared to untreated piglets.

November 21, 2017

·

1 min read

Drug Development

Menlo Therapeutics Begins Phase II Clinical Trial for Pruritus Associated with Psoriasis

The PSORIXA study, MTI-109, is a multi-center, randomized, placebo-controlled study evaluating the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus associated with psoriasis.

November 21, 2017

·

2 min read

Drug Development

NewLink Genetics Announces the Presentation of Indoximod Data in Phase I Study for Children

The presentation entitled, “Radio-chemo-immunotherapy using the IDO-inhibitor indoximod for children with progressive brain tumors in the phase 1 setting” showed the combination of indoximod plus radiation was well-tolerated.

November 21, 2017

·

3 min read

BioMidwest

Life Spine Announces Alpha Launch of SIMPACT TRI-FIN Sacroiliac Joint Fixation Screws

The SIMPACT TRI-FIN system was designed with an anti-rotational sleeve to inhibit component back out, and a screw thread design which affords the surgeon the ability to compress and stabilize the SI joint.

November 21, 2017

·

2 min read